You are here: Home Glossary A-E Angiogenesis Inhibitor
  • Increase font size
  • Default font size
  • Decrease font size
Search

mesothelioma

Angiogenesis Inhibitor

Angiogenesis Inhibitor Cancer research is currently at an all time high. Currently, there are numerous studies being conducted on whether or not Angiogenesis Inhibitors are a positive way to treat cancer. These drug compounds are able to block the development of new blood vessels for the body. The process of angiogenesis has been helping doctors and researchers determine whether or not the blockage of these new blood cells would allow the tumor to be cut off from oxygen and nutrients. If this process becomes successful study, cancerous tumors may be limited in size and prevented from spreading to other parts of the body. New blood cells are a vital part of why cancer inhabits certain locations in a person's body because the cancer requires nutrients and oxygen. These cancerous cells grow and feed off of the essential parts needed for healthy tissue. The cancer ends up invading the surrounding healthy organs not associated associated with the cancer site. Chemicals such as these inhibitors are becoming an important study tools because doctors are trying to come up with a safe and effective way to eliminate the production of cancer cells. The main focus is to force the cancer to shrink and eventually dies= off, leaving the patient cancer free. Unfortunately, this process is still experimental and whether it is an effective way to eliminate cancer is still under debate. It has been noted that animal research on these chemicals has been successful, completely eliminating the growth of cancer. Research studies on humans are still being performed to determine whether or not Angiogenesis Inhibitors are effective for different cancers including, breast, prostate, brain, pancreas, lung, stomach, ovary and cervix. It is important that scientists make sure that these types of chemicals are not only effective for the treatment of different types of cancer, but that they are safe for humans to ingest. Besides using Angiogenesis Inhibitors, it is important that the patient be able to maintain a healthy diet and lifestyle during these trials. A health care professional may suggest a patient to consume green tea, red wine (in moderation) and soy products because they possess similar natural inhibitors that could be helpful in the angiogenesis process.